Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Current Role of Radiation Therapy in the Management of Malignant Central Nervous System Tumors.

Farooqi A, Li J, de Groot J, Yeboa DN.

Hematol Oncol Clin North Am. 2020 Feb;34(1):13-28. doi: 10.1016/j.hoc.2019.08.015. Epub 2019 Oct 28. Review.

PMID:
31739940
2.

The role of radiotherapy in the management of high-grade meningiomas.

Hwang KL, Hwang WL, Bussière MR, Shih HA.

Chin Clin Oncol. 2017 Jul;6(Suppl 1):S5. doi: 10.21037/cco.2017.06.09. Review.

3.
4.

Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.

Kim M, Lee DH, Kim Rn HJ, Cho YH, Kim JH, Kwon DH.

Clin Neurol Neurosurg. 2017 Feb;153:93-101. doi: 10.1016/j.clineuro.2016.12.014. Epub 2016 Dec 29.

PMID:
28081463
5.

Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.

Ahluwalia M, Barnett GH, Deng D, Tatter SB, Laxton AW, Mohammadi AM, Leuthardt E, Chamoun R, Judy K, Asher A, Essig M, Dietrich J, Chiang VL.

J Neurosurg. 2018 May 4;130(3):804-811. doi: 10.3171/2017.11.JNS171273.

PMID:
29726782
6.

Central nervous system.

Adamson DC, Rasheed BA, McLendon RE, Bigner DD.

Cancer Biomark. 2010;9(1-6):193-210. doi: 10.3233/CBM-2011-0177. Review.

PMID:
22112477
7.

Strategies to Preserve Cognition in Patients With Brain Metastases: A Review.

Robin TP, Rusthoven CG.

Front Oncol. 2018 Oct 9;8:415. doi: 10.3389/fonc.2018.00415. eCollection 2018. Review.

8.

Effects of gamma knife radiosurgery for brain tumors: clinical evaluation.

Pan HC, Chung WY, Guo WY, Chang YC, Shiau CY, Wang LW, Liu RS, Ngo FQ, Lee LS.

Zhonghua Yi Xue Za Zhi (Taipei). 1998 Jul;61(7):397-407.

PMID:
9699392
9.

The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer.

Tanguturi S, Warren LEG.

Curr Oncol Rep. 2019 Apr 16;21(6):50. doi: 10.1007/s11912-019-0803-5. Review.

PMID:
30993546
10.

Diagnosis and treatment of atypical and anaplastic meningiomas: a review.

Modha A, Gutin PH.

Neurosurgery. 2005 Sep;57(3):538-50; discussion 538-50. Review.

PMID:
16145534
11.

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW.

Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9. Review.

PMID:
27157931
12.

Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis.

Sergentanis TN, Tsivgoulis G, Perlepe C, Ntanasis-Stathopoulos I, Tzanninis IG, Sergentanis IN, Psaltopoulou T.

PLoS One. 2015 Sep 2;10(9):e0136974. doi: 10.1371/journal.pone.0136974. eCollection 2015.

13.

The effect of radiosurgery during management of aggressive meningiomas.

Harris AE, Lee JY, Omalu B, Flickinger JC, Kondziolka D, Lunsford LD.

Surg Neurol. 2003 Oct;60(4):298-305; discussion 305.

PMID:
14505844
14.

Stereotactically delivered cranial radiation therapy: a ten-year experience of linac-based radiosurgery in the UK.

Sims E, Doughty D, Macaulay E, Royle N, Wraith C, Darlison R, Plowman PN.

Clin Oncol (R Coll Radiol). 1999;11(5):303-20. Review.

PMID:
10591819
15.

Stereotactic radiation treatment for recurrent nonbenign meningiomas.

Mattozo CA, De Salles AA, Klement IA, Gorgulho A, McArthur D, Ford JM, Agazaryan N, Kelly DF, Selch MT.

J Neurosurg. 2007 May;106(5):846-54.

PMID:
17542529
16.

The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Ryken TC, Parney I, Buatti J, Kalkanis SN, Olson JJ.

J Neurooncol. 2015 Dec;125(3):551-83. doi: 10.1007/s11060-015-1948-1. Epub 2015 Nov 3. Review.

PMID:
26530266
17.

Management of Central Nervous System Tumors.

Kaley T, Nabors LB.

J Natl Compr Canc Netw. 2019 May 1;17(5.5):579-582. doi: 10.6004/jnccn.2019.5012.

PMID:
31117044
18.

2016 World Health Organization Classification of Central Nervous System Tumors.

Wen PY, Huse JT.

Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1531-1547. doi: 10.1212/CON.0000000000000536. Review.

PMID:
29200109
19.

Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.

Wu A, Jin MC, Meola A, Wong HN, Chang SD.

Neurosurg Focus. 2019 Jun 1;46(6):E12. doi: 10.3171/2019.3.FOCUS1967.

PMID:
31153145
20.

Management of CNS disease in ALK-positive non-small cell lung cancer: Is whole brain radiotherapy still needed?

Wrona A.

Cancer Radiother. 2019 Sep;23(5):432-438. doi: 10.1016/j.canrad.2019.03.009. Epub 2019 Jul 19. Review.

PMID:
31331844

Supplemental Content

Support Center